BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine

  MabVax Therapeutics Holdings, Inc. has granted to Y-mAbs Therapeutics, Inc., an exclusive sublicense to a bi-valent ganglioside based vaccine intended to treat neuroblastoma

  July 3, 2018

   · 

  6 min read
• Genetown

  Promising Treatment of Challenging Pediatric Brain Stem Tumor, DIPG, with Alcyone AMC Precision Delivery of Oncolytic Adenovirus

  Alcyone Lifesciences, Inc. announced encouraging progress by investigators at the Clínica Universidad de Navarra regarding the Alcyone MEMS Cannula (AMC) precision delivery of an oncolytic adenovirus in a small series of patients with a pediatric brain stem tumor, diffuse intrinsic pontine glioma (DIPG).

  July 3, 2018

   · 

  3 min read
• Business

  Non-Profit Feeding Children Everywhere Pioneers Use of Artificial Intelligence to Combat Hunger

  AI plus EnableSoft technology help feed 200,000 more people per year

  July 3, 2018

   · 

  3 min read